2023-10-12 09:30:22 ET
DENVER, Colo., Oct 12, 2023 ( www.247marketnews.com )- Jaguar Health, Inc. (NASDAQ: JAGX) stated, this morning, that the company’s founder, president and CEO, will present and host one-on-one meetings with investors on October 17 and 18, 2023, and on October 18, 2023, with top line results expected in the coming weeks for company’s phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea
Jaguar Health is trading at $0.47, up $0.228 (+94.21%), on 44.7M premarket shares traded.
Its 52-week range is $0.2249 to $12.90. It basically spent the past week trading at its 52-week low and is trying to reverse that trend.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various …
The post Jaguar Health to Present at 2 upcoming Investor Conferences with Top line Results expected in the coming weeks appeared first on 24/7 Market News .
For further details see:
Jaguar Health to Present at 2 upcoming Investor Conferences with Top line Results expected in the coming weeks